As whyte indicated >>>its a pity the HC threads are sometimes invaded by a persistent and seemingly ignorant troll(s).
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea Initiates OPT-302 Diabetic Macular Edema Trial
Ann: Opthea Initiates OPT-302 Diabetic Macular Edema Trial, page-19
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
76.0¢ |
Change
-0.065(7.88%) |
Mkt cap ! $935.6M |
Open | High | Low | Value | Volume |
81.0¢ | 81.5¢ | 76.0¢ | $1.709M | 2.198M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 15846 | 76.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
77.0¢ | 2450 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 15846 | 0.760 |
1 | 11396 | 0.755 |
4 | 33409 | 0.750 |
1 | 1755 | 0.745 |
1 | 6500 | 0.740 |
Price($) | Vol. | No. |
---|---|---|
0.770 | 2450 | 1 |
0.780 | 12646 | 2 |
0.785 | 11396 | 1 |
0.790 | 40000 | 1 |
0.795 | 40000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online